Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2024 Aug 1;109(8):2395-2397.
doi: 10.3324/haematol.2024.285019.

More is not always better, sometimes it is just more

Antonio Salar Silvestre  1
Affiliations
Editorial

More is not always better, sometimes it is just more

Antonio Salar Silvestre. Haematologica. .
No abstract available

PubMed Disclaimer

Comment on

  • IELSG38: phase II trial of front-line chlorambucil plus subcutaneous rituximab induction and maintenance in mucosa-associated lymphoid tissue lymphoma.
    Stathis A, Pirosa MC, Orsucci L, Feugier P, Tani M, Ghesquières H, Musuraca G, Rossi FG, Merli F, Guièze R, Gyan E, Gini G, Marino D, Gressin R, Morschhauser F, Cavallo F, Palombi F, Conconi A, Tessoulin B, Tilly H, Zanni M, Cabras MG, Capochiani E, Califano C, Celli M, Pulsoni A, Angrilli F, Occhini U, Casasnovas RO, Cartron G, Devizzi L, Haioun C, Liberati AM, Houot R, Merli M, Pietrantuono G, Re F, Spina M, Landi F, Cavalli F, Bertoni F, Rossi D, Ielmini N, Borgo E, Luminari S, Zucca E, Thieblemont C. Stathis A, et al. Haematologica. 2024 Aug 1;109(8):2564-2573. doi: 10.3324/haematol.2023.283918. Haematologica. 2024. PMID: 38385243 Free PMC article. Clinical Trial.

References

    1. Stathis A, Pirosa MC, Orsucci L, et al. . IELSG38: phase 2 trial of frontline chlorambucil plus subcutaneous rituximab induction and maintenance in MALT lymphoma. Haematologica. 2024;109(8):2564-2573. - PMC - PubMed
    1. Cerhan JR, Habermann TM. Epidemiology of marginal zone lymphoma. Ann Lymphoma. 2021;5:1. - PMC - PubMed
    1. Campo E, Jaffe ES, Cook JR, et al. . The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee. Blood. 2022;140(11):1229-1253. - PMC - PubMed
    1. Salar A, Avivi I, Bittner B, et al. . Comparison of subcutaneous versus intravenous administration of rituximab as maintenance treatment for follicular lymphoma: results from a two-stage, phase IB study. J Clin Oncol. 2014;32(17):1782-1791. - PubMed
    1. Davies A, Merli F, Mihaljevic B, et al. . Pharmacokinetics and safety of subcutaneous rituximab in follicular lymphoma (SABRINA): stage 1 analysis of a randomised phase 3 study. Lancet Oncol. 2014;15(3):343-352. - PubMed

LinkOut - more resources